Related Experiment Video
Updated: Dec 27, 2025
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.0K
Mixed neuropathology in frontotemporal lobar degeneration
Catherine Pennington1,2, Luca Marini1, Elizabeth Coulthard1
1School of Clinical Sciences, University of Bristol, Bristol, UK.
Summary
Mixed neuropathology is common in frontotemporal lobar degeneration (FTLD), occurring in over 30% of cases. This suggests FTLD mixed pathologies impact diagnosis and patient outcomes.
Area of Science:
- Neuroscience
- Neuropathology
Background:
- Frontotemporal lobar degeneration (FTLD) is a major cause of dementia.
- The co-occurrence of FTLD with other neurodegenerative diseases is not well understood.
Purpose of the Study:
- To investigate the prevalence of mixed neuropathology in FTLD cases.
- To examine the relationship between mixed pathology, age at death, and diagnostic accuracy.
Main Methods:
- Analysis of clinicopathological data from 515 neuropathologically diagnosed FTLD cases.
- Utilized the UK Brain Bank Network database.
Main Results:
- 30.10% of FTLD cases exhibited mixed neuropathology.
- Clinical-neuropathological diagnostic concordance was lower in mixed pathology cases (38.71%) compared to single pathology cases (59.17%).
- Older age at death was associated with mixed neuropathology, with increasing age correlating with more pathologies.
Conclusions:
- Mixed neuropathology is frequent in FTLD and linked to increased age at death.
- Mixed pathologies may affect FTLD onset, clinical presentation, and diagnostic accuracy.
- Further research is needed to understand the impact of mixed neuropathologies on FTLD phenotypes and clinical trial eligibility.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
01:15Parkinson's Disease: Overview
1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
01:37Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
01:30Dementia
458
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
458
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K